This article has not necessarily been edited by Health24.
The agency also recommended that:
Patients taking GnRH agonists should be checked regularly for signs of the development of diabetes and cardiovascular disease.
Management of cardiovascular risk factors -- including smoking, as well as increases in blood pressure, cholesterol, blood sugar and weight -- should be stressed.
Those taking GnRH agonists should not stop the therapy unless instructed by their health-care provider.